散发性胰腺腺癌的流行病学及遗传易感性
Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.
作者信息
Stolzenberg-Solomon Rachael Z, Amundadottir Laufey T
机构信息
Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 6E420, Rockville, MD 20850, USA.
Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Circle, Bethesda, MD 20892, USA.
出版信息
Hematol Oncol Clin North Am. 2015 Aug;29(4):619-40. doi: 10.1016/j.hoc.2015.04.009.
Abstract
Given the changing demographics of Western populations, the numbers of pancreatic cancer cases are projected to increase during the next decade. Diabetes, recent cigarette smoking, and excess body weight are the cancer's most consistent risk factors. The search for common and rare germline variants that influence risk of pancreatic cancer through genome-wide association studies and high-throughput-sequencing-based studies is underway and holds the promise of increasing the knowledge of variants and genes that play a role in inherited susceptibility of this disease. Research reported in this review has advanced the understanding of pancreatic cancer.
摘要
鉴于西方人群人口结构的变化，预计未来十年胰腺癌病例数将会增加。糖尿病、近期吸烟和超重是该癌症最一致的风险因素。通过全基因组关联研究和基于高通量测序的研究来寻找影响胰腺癌风险的常见和罕见种系变异的工作正在进行中，有望增加对在该疾病遗传易感性中起作用的变异和基因的认识。本综述中报道的研究推进了对胰腺癌的理解。
相似文献
1
Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.散发性胰腺腺癌的流行病学及遗传易感性
Hematol Oncol Clin North Am. 2015 Aug;29(4):619-40. doi: 10.1016/j.hoc.2015.04.009.
2
Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.2 型糖尿病遗传易感性变异与胰腺癌风险的关联研究：PanScan-I 数据分析。
Cancer Causes Control. 2011 Jun;22(6):877-83. doi: 10.1007/s10552-011-9760-5. Epub 2011 Mar 29.
3
Epidemiology of pancreatic cancer: an overview.胰腺癌的流行病学：概述。
Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708. doi: 10.1038/nrgastro.2009.177. Epub 2009 Oct 6.
4
Association of breast cancer susceptibility variants with risk of pancreatic cancer.乳腺癌易感性变异与胰腺癌风险的关联。
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3044-8. doi: 10.1158/1055-9965.EPI-09-0306. Epub 2009 Oct 20.
5
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.遗传性胰腺癌易感性及其功能特征：PANcreatic Disease ReseArch（PANDoRA）联合会。
Dig Liver Dis. 2013 Feb;45(2):95-9. doi: 10.1016/j.dld.2012.09.014. Epub 2012 Dec 1.
6
Risk factors for pancreatic cancer: a case-control study based on direct interviews.胰腺癌的风险因素：一项基于直接访谈的病例对照研究。
Teratog Carcinog Mutagen. 2001;21(1):7-25. doi: 10.1002/1520-6866(2001)21:1<7::aid-tcm3>3.0.co;2-a.
7
Update on familial pancreatic cancer.家族性胰腺癌的最新进展。
Curr Gastroenterol Rep. 2001 Apr;3(2):121-8. doi: 10.1007/s11894-001-0008-5.
8
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.切除胰腺癌患者的种系癌症易感性基因变异、体细胞二次打击和生存结局。
Genet Med. 2019 Jan;21(1):213-223. doi: 10.1038/s41436-018-0009-5. Epub 2018 Jul 2.
9
Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.有非胰腺原发性癌症病史的患者中后续胰腺腺癌的发病率。
Cancer. 2012 Mar 1;118(5):1244-51. doi: 10.1002/cncr.26414. Epub 2011 Sep 1.
10
Evidence for a major gene influencing risk of pancreatic cancer.存在一个影响胰腺癌风险的主要基因的证据。
Genet Epidemiol. 2002 Aug;23(2):133-49. doi: 10.1002/gepi.1102.
引用本文的文献
1
Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts.两项前瞻性队列研究中诊断前血清代谢物与胰腺导管腺癌风险的关联
Int J Cancer. 2025 Oct 1;157(7):1304-1315. doi: 10.1002/ijc.35479. Epub 2025 May 22.
2
Global Burden of Pancreatic Cancer Attributable to High Body-Mass Index in 204 Countries and Territories, 1990-2019.1990 - 2019年204个国家和地区因高体重指数导致的胰腺癌全球负担
Cancers (Basel). 2024 Feb 8;16(4):719. doi: 10.3390/cancers16040719.
3
Artificial intelligence and improved early detection for pancreatic cancer.人工智能与胰腺癌早期检测的改善
Innovation (Camb). 2023 Jun 8;4(4):100457. doi: 10.1016/j.xinn.2023.100457. eCollection 2023 Jul 10.
4
A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer.CTRB2 中的 584bp 缺失抑制糜蛋白酶 B2 的活性和分泌，并增加胰腺癌的风险。
Am J Hum Genet. 2021 Oct 7;108(10):1852-1865. doi: 10.1016/j.ajhg.2021.09.002. Epub 2021 Sep 23.
5
The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients.东方胰腺癌患者基因改变分层预后的情况
Front Oncol. 2021 Jul 22;11:717989. doi: 10.3389/fonc.2021.717989. eCollection 2021.
6
Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients.以生物模型为特征的基因改变用于定制胰腺癌患者的临床管理。
Cancers (Basel). 2020 May 14;12(5):1233. doi: 10.3390/cancers12051233.
7
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.FAM84B 在胰腺导管腺癌中扩增，通过 Wnt/β-catenin 通路促进肿瘤发生。
Aging (Albany NY). 2020 Apr 14;12(8):6808-6822. doi: 10.18632/aging.103044.
8
Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.胰腺癌生物学建模：基于 3D PDX 衍生类器官和原代细胞系类器官发育的转录组特征。
Sci Rep. 2020 Feb 17;10(1):2778. doi: 10.1038/s41598-020-59368-7.
9
Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.在一项大型前瞻性流行病学研究中，代谢物与胰腺癌风险之间的关联。
Gut. 2020 Nov;69(11):2008-2015. doi: 10.1136/gutjnl-2019-319811. Epub 2020 Feb 14.
10
A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.全转录组关联研究鉴定出胰腺癌的新候选易感基因。
J Natl Cancer Inst. 2020 Oct 1;112(10):1003-1012. doi: 10.1093/jnci/djz246.
本文引用的文献
1
Risk factors for pancreatic cancer: a summary review of meta-analytical studies.胰腺癌的危险因素：荟萃分析研究综述。
Int J Epidemiol. 2015 Feb;44(1):186-98. doi: 10.1093/ije/dyu240. Epub 2014 Dec 14.
2
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.循环中支链氨基酸水平升高是人类胰腺腺癌发生过程中的早期事件。
Nat Med. 2014 Oct;20(10):1193-1198. doi: 10.1038/nm.3686. Epub 2014 Sep 28.
3
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡：GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
4
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.一项对87040名个体的荟萃分析确定了23个新的前列腺癌易感基因座。
Nat Genet. 2014 Oct;46(10):1103-9. doi: 10.1038/ng.3094. Epub 2014 Sep 14.
5
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.全基因组关联研究确定了胰腺癌的多个易感基因座。
Nat Genet. 2014 Sep;46(9):994-1000. doi: 10.1038/ng.3052. Epub 2014 Aug 3.
6
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.糖尿病、抗糖尿病药物与胰腺癌风险：来自国际胰腺癌病例对照研究联盟的分析
Ann Oncol. 2014 Oct;25(10):2065-2072. doi: 10.1093/annonc/mdu276. Epub 2014 Jul 23.
7
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.跨不同癌症类型的插补和基于子集的关联分析在5号染色体p15.33区域的TERT-CLPTM1L基因座中鉴定出多个独立风险位点。
Hum Mol Genet. 2014 Dec 15;23(24):6616-33. doi: 10.1093/hmg/ddu363. Epub 2014 Jul 15.
8
Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.二甲双胍与癌症风险及死亡率：一项考虑偏倚和混杂因素的系统评价与荟萃分析
Cancer Prev Res (Phila). 2014 Sep;7(9):867-85. doi: 10.1158/1940-6207.CAPR-13-0424. Epub 2014 Jul 1.
9
ABO blood groups and risk of cancer: a systematic review and meta-analysis.ABO血型与癌症风险：一项系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2014;15(11):4643-50. doi: 10.7314/apjcp.2014.15.11.4643.
10
Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.三项前瞻性队列研究中血清转化生长因子-β1与胰腺癌风险
Cancer Causes Control. 2014 Sep;25(9):1083-91. doi: 10.1007/s10552-014-0409-z. Epub 2014 Jun 10.
Zotero 插件